Latest Breaking News On - Sabrina martucci johnson - Page 6 : vimarsana.com

Brokers Issue Forecasts for Daré Bioscience, Inc s Q3 2023 Earnings (NASDAQ:DARE)

Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) – Brookline Capital Management issued their Q3 2023 earnings estimates for Daré Bioscience in a report released on Monday, June 5th. Brookline Capital Management analyst K. Dolliver expects that the biotechnology company will earn ($0.07) per share for the quarter. Brookline Capital Management currently has a “Buy” rating […]

Lisa walters hoffertSabrina martucci johnsonBlackrock incVanguard group incRenaissance technologiesMillennium managementBioscience incGet ratingBrookline capital managementCapital managementBioscience priceFunds weigh in on darState street corpStreet corpBioscience dailyDaré bioscience

Daré Bioscience, Inc (NASDAQ:DARE) to Post Q2 2023 Earnings of ($0 07) Per Share, Brookline Capital Management Forecasts

Daré Bioscience, Inc (NASDAQ:DARE) to Post Q2 2023 Earnings of ($0 07) Per Share, Brookline Capital Management Forecasts
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Sabrina martucci johnsonLisa walters hoffertRenaissance technologiesBlackrock incBioscience incYork mellon corpVanguard group incBioscience company profileCitigroup incGet ratingBrookline capital managementCapital managementBioscience stockFunds weigh in on darNew york mellon corpBioscience company

Dare Bioscience (DARE) Announces Publication of Phase 1/2 Pharmacokinetic, Safety and Pharmacodynamic Data for DARE-VVA1

Dare Bioscience (DARE) Announces Publication of Phase 1/2 Pharmacokinetic, Safety and Pharmacodynamic Data for DARE-VVA1
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDburns mcclellanSabrina martucci johnsonJake robisonLee rothAndrea thurmanBioscience incInternational menopause societyInternational menopauseMedical directorChief executive officerInvestigational new drugVulvovaginal atrophySildenafil cream

Contrasting Daré Bioscience (NASDAQ:DARE) and Apellis Pharmaceuticals (NASDAQ:APLS)

Daré Bioscience (NASDAQ:DARE – Get Rating) and Apellis Pharmaceuticals (NASDAQ:APLS – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk. Analyst Recommendations This is a breakdown of recent recommendations and […]

San diegoUnited statesSabrina martucci johnsonPascal deschateletsCedric francoisRogerl hawleyCandace rose deppLisa walters hoffertBioscience incApellis pharmaceuticalsApellis pharmaceuticals incGet ratingGiven darApellis pharmaceuticalAlec machielsBioscience daily

Daré Bioscience, Inc (NASDAQ:DARE) Sees Significant Decrease in Short Interest

Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 378,600 shares, a decrease of 25.9% from the April 30th total of 511,000 shares. Based on an average daily volume of 191,300 shares, the […]

United statesSabrina martucci johnsonLisa walters hoffertAmerica corpYork mellon corpMorgan stanleyCitigroup incBioscience incGet ratingBioscience priceNew york mellon corpCapital managementBioscience dailyDaré bioscienceNasdaq dare